ROSENBLUM MARK J (Exec VP Finance, Interim CFO) received a stock award from DECOY THERAPEUTICS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 11/5/2020ACC: 0001615219-20-000104
Officer· Exec VP Finance, Interim CFO
Since Sep 2019
+4.72K
Net shares
Net buyer
$2.6K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
4.72K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+4.72K
Price / share
$0.56
Trade value
$2.65K
% of position
39.4%
11/3/2020
12K→16.72K
Total
Net shares
+4.72K
Net value
$2.65K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/3/2020 | A · Award | +4.72K | $0.56 | $2.65K | 39.4% | 12K | 16.72K |
| Total | +4.72K | $2.65K | ||||||
Derivative Transactions0
No derivative transactions reported